Real-world performance of the MiniMed™ 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycemic control with each technology iteration of the MiniMed™ automated insulin delivery system.

B GrassiA M GómezL E CalliariD R FrancoM RaggioF RieraM CastroJ McVeanTim van den HeuvelA ArrietaJ CastañedaO Cohen

Published in: Diabetes, obesity & metabolism (2023)

Real-world Latin American MM780G users on average showed good glucose control, achieving international targets. Glycemic control increased with every technology iteration of the MM system, providing more automation each time. This article is protected by copyright. All rights reserved.

Keyphrases

glycemic control
blood glucose
type diabetes
weight loss
insulin resistance
machine learning
high throughput
metabolic syndrome
adipose tissue